CD8A and lung adenocarcinoma: Immune cell profiling also revealed different immune subpopulations and their features, such as low expression of CD8+ T cell marker genes linked with improved survival in lung adenocarcinoma (LUAD), but worse survival in lung squamous cell carcinoma (LUSC).